Novel Immunosuppression

Prof. Dr. med. Sonja Schrepfer (AG Transplant and Stem Cell Immunobiology)
PD Dr. Tobias Deuse (AG Herz- und Lungentransplantation)

We are investigating the novel immunosuppressants for their efficacy to prevent acute and chronic allograft rejection after heart and lung transplantation. E.g. the novel JAK3 inhibitor R348, the ePKC inhibitor V1-2, or the potassium channel inhibitor TRAM34.

Laufzeit seit 2006
Förderung durch: Stanford

Kooperationspartner:

  • Stanford Universität, Kalifornien, USA
    Cardiothoracic Surgery (CT)
    Prof. Dr. R.C. Robbins
    CT Surgery
  • Stanford Universität, Kalifornien, USA
    Pharmacology
    Prof. Dr. D. Mochly-Rosen
    Pharmacology
  • Stanford Universität, Kalifornien, USA
    Pathology
    Prof. Dr. A. Connolly
    Pathology
  • UC Davis, California
    Prof. Dr. Heike Wulff
    Website